Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: screening by electrophoresis
- PMID: 14633908
- DOI: 10.1373/clinchem.2003.026583
Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: screening by electrophoresis
Abstract
Background: Hemoglobin-based oxygen carriers (HBOCs) have recently been included in the International Olympic Committee and World Anti-Doping Agency lists of substances and methods prohibited in sports. To enforce this rule and deter abuse of HBOCs in elite sports, it is necessary to develop HBOC-specific screening and confirmation tests that are the usual steps in antidoping control analysis.
Methods: We developed a screening method based on electrophoresis of serum samples cleared of haptoglobin (Hp). Four successive steps (immunoprecipitation of Hp, electrophoresis of the cleared serum, Western blotting of the separated proteins, and detection of hemoglobin-related molecules based on the peroxidase properties of the heme moiety), provided electropherograms that could be easily interpreted in terms of the presence of HBOCs. This method was tested with serum samples enriched with various types of HBOCs: polymerized, conjugated, and cross-linked hemoglobins. It was also applied to blood samples collected from 12 healthy volunteers who had been infused with either 30 or 45 g of Hemopure, a glutaraldehyde-polymerized bovine hemoglobin.
Results: The method clearly detected the presence in serum of the various types of HBOCs tested and demonstrated no possible confusion with endogenous hemoglobin that may be present in cases of hemolysis. The test was able to detect Hemopure for 4-5 days after administration of 45 g to healthy individuals.
Conclusions: The electrophoretic method is a simple, fast, and sensitive procedure that appears to fulfill the criteria of a screening test for the presence of HBOCs in antidoping control samples.
Similar articles
-
Detection of hemoglobin-based oxygen carriers in human serum for doping analysis: confirmation by size-exclusion HPLC.Clin Chem. 2004 Apr;50(4):723-31. doi: 10.1373/clinchem.2003.026591. Epub 2004 Feb 5. Clin Chem. 2004. PMID: 14764640
-
Application of HBOCs electrophoretic method to detect a new blood substitute derived from the giant extracellular haemoglobin of lugworm.Drug Test Anal. 2017 Nov;9(11-12):1762-1767. doi: 10.1002/dta.2127. Epub 2017 Jan 13. Drug Test Anal. 2017. PMID: 27787946
-
Doping control analysis of bovine hemoglobin-based oxygen therapeutics in human plasma by LC-electrospray ionization-MS/MS.Anal Chem. 2003 Jul 15;75(14):3287-93. doi: 10.1021/ac034434z. Anal Chem. 2003. PMID: 14570175
-
Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products.Curr Drug Discov Technol. 2012 Sep;9(3):158-65. doi: 10.2174/157016312802650742. Curr Drug Discov Technol. 2012. PMID: 21745179 Review.
-
[Oxygen blood transport and doping].Bull Acad Natl Med. 2003;187(9):1669-79; discussion 1680-3. Bull Acad Natl Med. 2003. PMID: 15369237 Review. French.
Cited by
-
Blood doping : infusions, erythropoietin and artificial blood.Sports Med. 2007;37(4-5):389-91. doi: 10.2165/00007256-200737040-00030. Sports Med. 2007. PMID: 17465616
-
Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.Br J Pharmacol. 2008 Jun;154(3):529-41. doi: 10.1038/bjp.2008.89. Epub 2008 Mar 24. Br J Pharmacol. 2008. PMID: 18362898 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous